NuCana (NCNA) Stock Chart & Stock Price History → The Tesla Indicator Is Bullish (From WealthPress) (Ad) Free NCNA Stock Alerts $3.63 +0.11 (+3.13%) (As of 05/28/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends NuCana Stock Price Performance5 Day Performance+3.13%1 Month Performance-9.25%3 Month Performance-54.63%6 Month Performance-68.43%Year-To-Date Performance-50.91%1 Year Performance-82.92% Receive NCNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NuCana and its competitors with MarketBeat's FREE daily newsletter Email Address Ad WealthPressThis TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.But I can promise that you’ll see all the details for yourself here. NCNA Stock Chart for Wednesday, May, 29, 2024 NCNA Chart by TradingView NuCana Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/28/2024$3.52$3.63+3.13%$3.85$3.536,492 shs$9.58 million05/27/2024$3.52$3.52$3.75$3.529,500 shs$9.29 million05/24/2024$3.54$3.52-0.42%$3.75$3.528,954 shs$9.30 million05/23/2024$3.59$3.54-1.53%$3.86$3.545,286 shs$9.33 million05/22/2024$3.55$3.59+1.13%$3.70$3.4614,493 shs$9.48 million05/21/2024$3.60$3.55-1.39%$3.78$3.4514,980 shs$9.37 million Get the Latest News and Ratings for NCNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NuCana and its competitors with MarketBeat's FREE daily newsletter. 05/20/2024$3.57$3.60+0.84%$3.74$3.4764,563 shs$9.50 million05/17/2024$3.70$3.60-2.70%$3.79$3.5622,093 shs$9.50 million05/16/2024$3.80$3.70-2.63%$3.87$3.6714,909 shs$9.77 million05/15/2024$3.78$3.80+0.53%$3.98$3.7724,956 shs$10.03 million05/14/2024$3.73$3.78+1.34%$3.88$3.6814,073 shs$9.98 million05/13/2024$3.59$3.73+3.90%$3.87$3.5419,482 shs$9.85 million05/10/2024$3.50$3.56+1.71%$3.62$3.4115,818 shs$7.38 million05/09/2024$3.76$3.50-6.91%$3.81$3.4135,324 shs$7.61 million05/08/2024$3.91$3.76-3.84%$4.34$3.53328,945 shs$7.78 million05/07/2024$3.88$3.91+0.77%$4.01$3.875,505 shs$8.09 million05/06/2024$4.00$3.88-3.00%$4.00$3.8731,444 shs$8.03 million05/03/2024$3.97$3.95-0.38%$4.18$3.8928,655 shs$8.18 million05/02/2024$3.98$3.97-0.38%$4.04$3.858,398 shs$8.21 million05/01/2024$4.01$3.98-0.75%$4.10$3.836,268 shs$8.24 million04/30/2024$4.00$4.01+0.25%$4.01$3.849,408 shs$8.30 million04/29/2024$4.00$4.00$4.28$3.9613,808 shs$8.28 million04/26/2024$3.84$4.00+4.17%$4.00$3.857,152 shs$8.36 million04/25/2024$3.83$3.84+0.26%$4.00$3.5416,490 shs$8.03 million04/24/2024$4.00$3.83-4.25%$4.09$3.7512,017 shs$8.01 million04/23/2024$3.99$4.00+0.25%$4.13$3.8237,241 shs$8.36 million04/22/2024$3.78$3.99+5.70%$4.20$3.8150,827 shs$8.34 million04/19/2024$3.79$3.78-0.26%$3.82$3.4032,622 shs$7.90 million04/18/2024$3.97$3.79-4.53%$4.18$3.6188,508 shs$7.92 million04/17/2024$3.90$3.97+1.79%$4.40$3.84108,050 shs$207.59 million04/16/2024$4.45$3.90-12.36%$5.14$3.69121,259 shs$203.93 million04/15/2024$5.60$4.45-20.50%$5.68$4.4431,893 shs$9.31 million04/12/2024$5.92$5.60-5.37%$5.98$5.3810,438 shs$11.71 million04/11/2024$5.92$5.92$5.99$5.754,879 shs$12.37 million04/10/2024$5.92$5.92-0.04%$5.93$5.639,024 shs$12.37 million04/09/2024$5.90$5.92+0.30%$6.10$5.6412,318 shs$12.38 million04/08/2024$5.82$5.90+1.42%$6.04$5.6712,574 shs$12.34 million04/05/2024$6.00$5.82-2.96%$6.10$5.6510,163 shs$12.17 million04/04/2024$6.56$6.00-8.58%$6.56$5.617,114 shs$12.54 million04/03/2024$5.75$6.56+14.14%$6.56$5.6018,072 shs$13.72 millionYour $200 account credit is about to expire (Ad)Update to MarketBeat All Access and Save $200 on Your Annual Subscription.Start Your Risk-Free Trial Here04/02/2024$5.93$5.75-3.04%$6.13$5.6125,075 shs$12.02 million04/01/2024$6.50$5.93-8.85%$6.28$5.6820,407 shs$12.39 million03/29/2024$6.50$6.50$6.88$5.8651,815 shs$13.60 million03/28/2024$7.81$6.50-16.75%$6.88$5.8651,607 shs$13.60 million03/27/2024$7.70$7.81+1.40%$7.81$7.3119,979 shs$16.33 million03/26/2024$7.85$7.70-1.85%$7.85$7.0118,932 shs$16.11 million03/25/2024$7.60$7.85+3.19%$8.08$7.5013,090 shs$16.41 million03/22/2024$7.24$7.60+4.97%$7.86$7.2515,199 shs$15.90 million03/21/2024$8.32$7.24-12.92%$8.50$7.2341,385 shs$15.15 million03/20/2024$8.36$8.32-0.51%$8.50$8.1010,053 shs$17.40 million03/19/2024$9.18$8.36-8.88%$8.75$8.1318,339 shs$17.49 million03/18/2024$8.72$9.18+5.25%$9.50$7.6349,954 shs$19.19 million03/15/2024$9.77$8.72-10.77%$9.25$8.1684,659 shs$18.23 million03/14/2024$10.50$9.77-6.95%$10.50$9.03163,012 shs$20.44 million03/13/2024$9.77$10.50+7.47%$19.30$10.502.57 million shs$21.96 million03/12/2024$8.25$9.77+18.42%$11.00$8.00623,865 shs$20.44 million03/11/2024$8.29$8.25-0.42%$8.48$7.751,984 shs$17.26 million03/08/2024$8.25$8.29+0.42%$8.50$7.564,429 shs$17.33 million03/07/2024$8.06$8.25+2.39%$8.25$7.5111,186 shs$17.26 million03/06/2024$8.23$8.06-2.04%$8.45$7.907,450 shs$16.85 million03/05/2024$8.25$8.23-0.30%$8.73$7.882,192 shs$17.20 million03/04/2024$8.00$8.25+3.13%$9.00$7.887,190 shs$17.26 million03/01/2024$8.00$8.00$8.38$7.632,735 shs$16.73 million02/29/2024$8.21$8.00-2.53%$8.50$7.972,767 shs$16.73 million02/28/2024$8.25$8.21-0.52%$8.75$8.001,635 shs$17.17 million Related Companies: Molecular Templates Stock Chart Universe Pharmaceuticals Stock Chart Addex Therapeutics Stock Chart Alterity Therapeutics Stock Chart Chemomab Therapeutics Stock Chart Kintara Therapeutics Stock Chart Can-Fite BioPharma Stock Chart Aeterna Zentaris Stock Chart Vaccinex Stock Chart Graybug Vision Stock Chart Receive NCNA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NuCana and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NCNA) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NuCana plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.